{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:28:35Z","timestamp":1788352115565,"version":"build-2803163510"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"26","license":[{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6,28]]},"abstract":"<jats:p>Our aim is to evaluate serum Raftlin levels as a biomarker for diagnosing and monitoring disease activity in patients with axial spondyloarthritis (axSpA) and Psoriatic arthritis (PsA). This trial included 40 axSpA patients, 40 PsA patients, and 40 healthy participants as the control group. Disease activity was assessed with Ankylosing Spondylitis Disease Activity Score for axSpA patients and The Disease Activity Index for Psoriatic Arthritis for PsA patients. The Spondyloarthritis Research Consortium of Canada index, health assessment questionnaire-disability index, and numeric rating scale were used to evaluate the enthesitis severity, disability, and pain status of all patients. Serum Raftlin levels were determined using the ELISA method. The 3 groups had no statistical differences regarding gender, age, weight, height, BMI, educational status, and exercise habits. The axSpA group had higher Raftlin levels than the PsA and control groups, and Raftlin levels were statistically significant in predicting the likelihood of axSpA. We found no statistically significant differences between the PsA and control groups. We found no statistically significant difference in Raftlin levels in HLA-B27 positive versus HLA-B27 negative patients in both axSpA and PsA groups. Our results also did not detect any correlation of Raftlin levels with Ankylosing Spondylitis Disease Activity Score, C-reactive protein, erythrocyte sedimentation rate, health assessment questionnaire-disability index, numeric rating scale, and Spondyloarthritis Research Consortium of Canada index in axSpA patients. Receiver operating characteristic analysis determined that Raftlin level\u2005\u2265\u20056.31\u2009ng\/mL discriminates axSpA from normal individuals with 92.5% sensitivity, 59% specificity, and an area under the curve of 0.738. Our results demonstrate that although serum Raftlin levels are elevated in axSpA patients, Raftlin cannot be used as an alone diagnostic marker for axSpA. Furthermore, it was not found to be related to the monitoring of disease activity, the level of pain, disability, or severity of enthesitis. This study is prospectively registered at www.clinicaltrials.gov (ID: NCT05771389).<\/jats:p>","DOI":"10.1097\/md.0000000000038770","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T14:48:09Z","timestamp":1719586089000},"page":"e38770","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Raftlin \u2013 a potential biomarker for axial spondyloarthritis and psoriatic arthritis: An observational study"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4567-8133","authenticated-orcid":false,"given":"Ozan Volkan","family":"Yurdakul","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Department of Physical Medicine and Rehabilitation, Bezmialem Vakif University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0042-4156","authenticated-orcid":false,"given":"Mert","family":"Kara","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Physical Medicine and Rehabilitation, Bezmialem Vakif University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7467-4073","authenticated-orcid":false,"given":"Bugra","family":"Ince","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Physical Medicine and Rehabilitation, Izmir City Hospital, University of Health Sciences, Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2047-7271","authenticated-orcid":false,"given":"Caner","family":"Yildiz","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Medical Biochemistry, Bezmialem Vakif University, Istanbul, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3885-9227","authenticated-orcid":false,"given":"Tugce","family":"Yildiz","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Medical Biochemistry, Bezmialem Vakif University, Istanbul, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6303-5735","authenticated-orcid":false,"given":"Mehmet Serkan","family":"Kilicoglu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Physical Medicine and Rehabilitation, Bezmialem Vakif University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0902-6771","authenticated-orcid":false,"given":"Teoman","family":"Aydin","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Physical Medicine and Rehabilitation, Bezmialem Vakif University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9034-4805","authenticated-orcid":false,"given":"Omer Faruk","family":"Ozer","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Medical Biochemistry, Bezmialem Vakif University, Istanbul, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260223","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00002281-200107000-00006","article-title":"Ankylosing spondylitis and undifferentiated spondyloarthropathies: a clinical review and description of a disease subset with older age at onset.","volume":"13","author":"Olivieri","year":"2001","journal-title":"Curr Opin Rheumatol"},{"key":"R2-20260223","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/acr.22831","article-title":"Global prevalence of spondyloarthritis: a systematic review and meta-regression analysis.","volume":"68","author":"Stolwijk","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R3-20260223","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.berh.2010.05.009","article-title":"Soluble and tissue biomarkers in ankylosing spondylitis.","volume":"24","author":"de Vlam","year":"2010","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R4-20260223","first-page":"980","article-title":"Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis.","volume":"26","author":"Spoorenberg","year":"1999","journal-title":"J Rheumatol"},{"key":"R5-20260223","first-page":"966","article-title":"Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review.","volume":"26","author":"Ruof","year":"1999","journal-title":"J Rheumatol"},{"key":"R6-20260223","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1194\/jlr.E600002-JLR200","article-title":"Rafts defined: a report on the keystone symposium on lipid rafts and cell function.","volume":"47","author":"Pike","year":"2006","journal-title":"J Lipid Res"},{"key":"R7-20260223","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/35036052","article-title":"Lipid rafts and signal transduction.","volume":"1","author":"Simons","year":"2000","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R8-20260223","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.4049\/jimmunol.0802672","article-title":"A major lipid raft protein Raftlin modulates T cell receptor signaling and enhances th17-mediated autoimmune responses.","volume":"182","author":"Saeki","year":"2009","journal-title":"J Immunol"},{"key":"R9-20260223","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1093\/emboj\/cdg293","article-title":"The B cell-specific major raft protein, Raftlin, is necessary for the integrity of lipid raft and BCR signal transduction.","volume":"22","author":"Saeki","year":"2003","journal-title":"EMBO J"},{"key":"R10-20260223","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/09687860500453673","article-title":"Lipid rafts in T cell receptor signalling.","volume":"23","author":"Kabouridis","year":"2006","journal-title":"Mol Membr Biol"},{"key":"R11-20260223","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/annrheumdis-2019-215356","article-title":"The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies.","volume":"78","author":"McGonagle","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"R12-20260223","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R13-20260223","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study.","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R14-20260223","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s11325-020-02161-7","article-title":"Evaluation of preoperative and postoperative serum interleukin-6, interleukin-8, tumor necrosis factor \u03b1 and Raftlin levels in patients with obstructive sleep apnea.","volume":"25","author":"Bilal","year":"2021","journal-title":"Sleep Breath"},{"key":"R15-20260223","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/ard.2010.138594","article-title":"Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores.","volume":"70","author":"Machado","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R16-20260223","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/ard.2009.122259","article-title":"Application of the DAREA\/DAPSA score for assessment of disease activity in psoriatic arthritis.","volume":"69","author":"Schoels","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R17-20260223","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/art.21445","article-title":"Spondyloarthritis research Consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis.","volume":"53","author":"Maksymowych","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R18-20260223","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/art.1780230202","article-title":"Measurement of patient outcome in arthritis.","volume":"23","author":"Fries","year":"1980","journal-title":"Arthritis Rheum"},{"key":"R20-20260223","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/00401706.1964.10490181","article-title":"Multiple comparisons using rank sums.","volume":"6","author":"Dunn","year":"1964","journal-title":"Technometrics"},{"key":"R22-20260223","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nri726","article-title":"Lipid rafts and B-cell activation.","volume":"2","author":"Pierce","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"R23-20260223","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17.","volume":"6","author":"Park","year":"2005","journal-title":"Nat Immunol"},{"key":"R24-20260223","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/cei.12670","article-title":"The interleukin (IL)-23\/IL-17 axis in ankylosing spondylitis: new advances and potentials for treatment.","volume":"183","author":"Jethwa","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"R25-20260223","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jaut.2009.02.010","article-title":"Microbial antigens mediate HLA-B27 diseases via TLRs.","volume":"32","author":"P\u00f6ll\u00e4nen","year":"2009","journal-title":"J Autoimmun"},{"key":"R27-20260223","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/acr.21688","article-title":"Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?","volume":"64","author":"Kiltz","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R28-20260223","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/art.24483","article-title":"The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort.","volume":"60","author":"Rudwaleit","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R29-20260223","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/1756-185X.13487","article-title":"HLA-B27 prevalence in axial spondyloarthritis patients and in blood donors in a Lebanese population: results from a nationwide study.","volume":"22","author":"Ziade","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"R30-20260223","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/ard.2003.011247","article-title":"How to diagnose axial spondyloarthritis early.","volume":"63","author":"Rudwaleit","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"R31-20260223","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1136\/ard.2008.100826","article-title":"ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis.","volume":"68","author":"van der Heijde","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R32-20260223","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s10753-013-9788-7","article-title":"Raftlin: a new biomarker in human sepsis.","volume":"37","author":"Lee","year":"2014","journal-title":"Inflammation"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038770","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T22:01:59Z","timestamp":1771884119000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,28]]},"references-count":29,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000038770","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,28]]}}}